Emerging Players Threaten Novo Nordisk and Eli Lilly’s Weight Loss Drug Dominance
Learn more about how Amgen and other emerging players are challenging the dominance of Novo Nordisk and Eli Lilly in the weight loss drug market. Explore the latest developments in this competitive industry.